Dr. Thomas O. Steedle, MD

Dr. Steedle practices at Florida Eye Clinic Ambulatory Surgical Center in Altamonte Springs, Florida.

Dr. Steedle's NPI, 1548251515, was assigned on October 31, 2005. Dr. Steedle graduated from University of Pittsburgh School of Medicine in 1976. Dr. Steedle holds Florida license ME47082.

Dr. Steedle's primary practice is Florida Eye Clinic Ambulatory Surgical Center, at 160 Boston Ave, Altamonte Springs, FL 32701 in Seminole County. The practice phone is (407) 834-7776.

Dr. Steedle's primary practice is Florida Eye Clinic Ambulatory Surgical Center in Altamonte Springs, Florida. Dr. Steedle is also affiliated with AdventHealth Orlando. Dmand AI also links Dr. Steedle to 1 more ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Steedle practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Steedle's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Steedle is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Steedle's licenses on file in 2 states: Florida and Ohio.

Dmand AI lists cataract, cold sores or genital herpes, conjunctivitis, eye infection or inflammation, eyelid inflammation, glaucoma, inflammation of iris and scleritis among the conditions Dr. Steedle treats.

CMS data shows 606 Medicare services from Dr. Steedle across 12 procedure codes in 2024, for 369 Medicare patients. Medicare paid $45,146 for them. Every service was in an office.

CMS counts 369 Medicare patients who saw Dr. Steedle in 2024. The largest group is 75 to 84, with 153 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Steedle's median patient age at 67, with 64% women.

In 2024, Dr. Steedle wrote 1,556 Medicare Part D claims for 570 patients. 76% of them were for generic drugs. CMS names the drug for 1,470 of them, across 15 drugs with 11 or more claims each, at $33,787 in total drug cost. In 2023, CMS named 1,616 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Steedle for performance year 2024, reported as part of a group. Dr. Steedle accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Steedle. The most frequent topics are Cataract, Sunlight and Vision Tests. Dr. Steedle has published most often in J Cataract Refract Surg.

CMS Open Payments shows 44 general payments to Dr. Steedle from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Allergan Inc. paid the most, $412.

Dmand AI lists 2 awards for Dr. Steedle, most recently CMS Stage 1 EHR in 2013.

Dr. Steedle graduated from University of Pittsburgh School of Medicine in 1976. Dr. Steedle is a member of AAO.

Dr. Steedle is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.